⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for refractory glioblastoma

Every month we try and update this database with for refractory glioblastoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBMNCT04003649
Recurrent Gliob...
Refractory Glio...
IL13Ralpha2-spe...
Ipilimumab
Nivolumab
Quality-of-Life...
Questionnaire A...
18 Years - City of Hope Medical Center
VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBMNCT03149575
Glioblastoma Mu...
Glioblastoma
Glioma
GBM
Brain Cancer
VAL-083, Dianhy...
Physician's Cho...
Physician's Cho...
Physician's Cho...
18 Years - Kintara Therapeutics, Inc.
B7-H3 CAR-T for Recurrent or Refractory GlioblastomaNCT04077866
Recurrent Gliob...
Refractory Glio...
Temozolomide
B7-H3 CAR-T
18 Years - 75 YearsSecond Affiliated Hospital, School of Medicine, Zhejiang University
Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant GliomaNCT02208362
Recurrent Gliob...
Recurrent Malig...
Recurrent WHO G...
Recurrent WHO G...
Refractory Glio...
Refractory Mali...
Refractory WHO ...
Refractory WHO ...
IL13Ralpha2-spe...
IL13Ralpha2-spe...
Laboratory Biom...
Magnetic Resona...
Magnetic Resona...
Quality-of-Life...
12 Years - 75 YearsCity of Hope Medical Center
Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory GlioblastomaNCT04385173
Recurrent Gliob...
Refractory Glio...
B7-H3 CAR-T
Temozolomide
18 Years - 75 YearsSecond Affiliated Hospital, School of Medicine, Zhejiang University
Pilot Study of Elemene in Treating Patients With Refractory GlioblastomaNCT04674527
Refractory Glio...
Elemene
Temozolomide
18 Years - Second Affiliated Hospital, School of Medicine, Zhejiang University
IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBMNCT04003649
Recurrent Gliob...
Refractory Glio...
IL13Ralpha2-spe...
Ipilimumab
Nivolumab
Quality-of-Life...
Questionnaire A...
18 Years - City of Hope Medical Center
Safety Study of VAL-083 in Patients With Recurrent Malignant GliomaNCT01478178
Glioma
Glioblastoma
Glioblastoma Mu...
GBM
Brain Cancer
VAL-083 (Dianhy...
18 Years - Kintara Therapeutics, Inc.
Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent SettingNCT02717962
Glioma
Glioblastoma
Glioblastoma Mu...
GBM
Brain Cancer
VAL-083, Dianhy...
18 Years - Kintara Therapeutics, Inc.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: